Because MH is a cardiovascular risk and can be reversed by thyroid hormone replacement, its presence should represent an indication for thyroid hormone replacement therapy also in patients with s-HYPO.
Introduction
Thyroid hormones have profound cardiovascular effects, including control of arterial blood pressure (BP) [1] . Previous studies suggested that BP regulation can be altered across the whole spectrum of thyroid dysfunction. Indeed, arterial hypertension is frequently observed in both hyperthyroidism and hypothyroidism [2] [3] [4] [5] , thus suggesting different underlying pathophysiological mechanisms. In hypothyroidism, hemodynamic changes are characterized by a lower cardiac output, due to decreased basal heart rate (HR) and negative inotropic effects, as well as by increased systemic arterial resistance. In most available studies, overt hypothyroidism (o-HYPO) is frequently associated with diastolic hypertension [6] [7] [8] , mainly due to both increased systemic vascular resistance [6] and arterial stiffness [9] . After total thyroidectomy, levothyroxine (L-T 4 ) replacement therapy discontinuation may lead to an increase in BP values, particularly diastolic; these changes can be reversed by reintroducing L-T 4 [10] , suggesting that even short-term o-HYPO may affect the BP homeostasis. With regard to subclinical hypothyroidism (s-HYPO), defined as increased serum TSH and normal serum free T 4 (FT 4 ) levels, relation with BP is controversial. Some studies in women found a relation similar to o-HYPO [11, 12] , while others reported no association [13] [14] [15] [16] [17] .
Abstract
Purpose Masked hypertension (MH) is the association of normal office blood pressure (BP) with high ambulatory or home BP. This condition is associated with increased cardiovascular target organ damage, as true hypertension. Because the relation with hypothyroidism is controversial, we investigated it in a pilot longitudinal and controlled study. Methods We consecutively enrolled 64 newly diagnosed hypothyroid patients, 38 subclinical (s-HYPO), and 26 overt (o-HYPO). The control group consisted of 50 euthyroid subjects seen at outpatient clinics. All participants underwent office and 24-h ambulatory BP measurement. Results BP monitoring revealed a higher prevalence of MH both in s-HYPO (26.3 %) and in o-HYPO (15.4 %) than in euthyroid subjects (10 %, p = 0.05); true hypertension also was more frequent in o-HYPO (11.5 %) and s-HYPO (10.5 %) than in controls (8 %, p = 0.03). The odds ratio for hypertension versus normotension confirmed a significantly increased risk of MH in hypothyroid patients versus euthyroid subjects (3.29, 1.08-10.08; p = 0.02). In a subgroup of patients reevaluated after restoration of euthyroidism, an improvement of BP profile was observed, especially in s-HYPO subgroup, with a decreased prevalence of MH (from 25 to 10.7 %) and true hypertension (from 10.7 to 3.4 %). Conclusions Hypothyroidism may be an important predictor of higher BP values, with an increased risk of MH.
Masked hypertension (MH) (or isolated ambulatory hypertension) is a condition in which BP is normal in the office and abnormally high out of the medical environment, either on ambulatory BP monitoring (ABPM) or home BP monitoring (HBPM) [18] . According to the recent European Society of Hypertension and the European Society of Cardiology Guidelines for the management of arterial hypertension [19] , MH is defined by an office BP <140/90 mmHg together with an out-of-office daytime or home BP ≥135 and/or 85 mmHg or mean 24-h BP ≥130 and/or 80 mmHg. Meta-analyses of prospective studies indicate that MH is associated with target organ damage, with an incidence of cardiovascular events similar to that of true (or sustained) hypertension (TH). This eventually leads to increased mortality [20] [21] [22] , possibly due to the fact that MH is largely undetected and, therefore, not treated. Thus, individuals with MH should be carefully and early investigated for hypertensive cardiac damage and provided with appropriate therapeutic intervention [23] .
While prevalence of MH in the general population averages 13 % [20] , information regarding the prevalence of MH in thyroid diseases is scant [24] . Based on these premises, we performed a cohort study aimed at evaluating the prevalence of MH in newly diagnosed o-HYPO and s-HYPO patients without cardiovascular abnormalities or treatments.
Materials and methods

Subjects
Consecutive patients with newly diagnosed (and untreated) o-or s-HYPO attending our endocrinology outpatient clinic were recruited. Other inclusion criteria were: no past or current antihypertensive treatment, no treatment potentially increasing BP, no evidence of cardiac diseases and diabetes, age >18 years.
Sixty-four Caucasian patients (58 women, 6 men, mean age 45.3 ± 12.4 years, range 26-71 years) were enrolled during the period 2010-2014. Patients had either o-HYPO (n = 26) with serum TSH concentration >5 mU/l and low serum FT 4 concentration (<7.8 pg/ml), or s-HYPO (n = 38) with increased serum TSH and normal serum FT 4 concentration. Hypothyroidism was due to chronic autoimmune (Hashimoto's) thyroiditis in all cases but one (interferoninduced hypothyroidism). The control group consisted of 50 Caucasian euthyroid volunteers (38 women, 12 men, mean age 46.3 ± 13.7 years, range 26-71 years) with nodular thyroid disease affecting neither thyroid function nor BP, attending the same outpatient clinic.
A short questionnaire about family history for hypertension and personal habits (smoking, caffeine and alcohol consumption, and daily physical activity) was administered to both patients and controls.
Each participant underwent physical examination, including measurement of anthropometric indices, office BP measurements, 24-h ABPM, and laboratory assessment.
All patients and controls gave their informed consent to participate in the study, which was approved by the Institutional Ethics Committee.
Anthropometric indices
Body weight and height were measured with the subjects in light clothing without shoes. Body mass index (BMI) was calculated by dividing body mass (kg) by height (squared meters), and classified according to the National Institute of Health (NIH) recommendations on BMI cutoffs [25] . Waist circumference was measured by a conventional soft measure tape according to WHO indications [26] . To identify a visceral pattern of body fat distribution, according to the International Diabetes Federation consensus worldwide definition of the metabolic syndrome, we referred to ethnicspecific values for waist circumference recommended for the Caucasian population (male ≥94 cm, female ≥80 cm) [27] .
Office BP measurements
Office BP was measured by a physician responsible for the study (E.P.), using a mercury calibrated sphygmomanometer. An appropriate-size cuff was applied around the nondominant arm, and systolic and diastolic values were identified from the first and fifth phase of Korotkoff sounds. In all participants, the mean of three consecutive measurements (5 min apart) performed during the clinic visit, at rest in the morning, in a sitting position, with the arm comfortably placed at heart level, was considered.
ABPM
Non-invasive 24-h ABPM was performed in all participants on a working day, using a portable, automated TM-2430 device (A&D Company Limited, Tokyo). During monitoring, subjects were encouraged to behave in the usual way (normal working and/or daily activities) and to write a diary (wake-up and sleeping time, most relevant activities). The unit was set to take readings of BP and HR at 15-min intervals throughout the 24-h study period. Stored values were analyzed by S.I.G.M.A. 2000 program (I-Tec S.r.l.). The following parameters were evaluated: mean 24-h, daytime (from 0700 to 2300 hours), and nighttime (from 2300 to 0700 hours) systolic and diastolic BP; mean 24-h, daytime, and nighttime HR; and percent nighttime BP fall. Individuals were defined as dippers or non-dippers when nighttime BP fall was ≥10 % or <10 %, respectively [28] . ABPM records had to contain at least 80 % valid BP measurements, automatically excluding systematic errors, as systolic BP >280 and/or <60 mmHg, and diastolic BP >160 and/or <40 mmHg. According to results of both office and 24-h ABPM, hypothyroid patients and euthyroid controls were characterized as confirmed normotensive or hypertensive individuals, and they were divided into four categories: TH, MH, white coat hypertension (WH), and true normotension (TN) [19] . Following the 2013 European Society of Hypertension and the European Society of Cardiology Guidelines (Table 1) , MH was diagnosed as office normotension (BP <140/90 mmHg) and ambulatory hypertension (24-h BP ≥130 and/or 80 mmHg).
Blood samples
Fasting venous blood samples were taken after an overnight fast and a proper abstinence from physical activity, smoking, alcohol and caffeine consumption, in the morning between 0800 and 0900 hours, from the antecubital vein of the participants before application of the BP-monitoring device. Assays were performed centrally at the core laboratory. Serum TSH and FT 4 were measured by specific RIAs (Liason ® Dia Sorin). Reference ranges are: TSH 0.31-5 mU/l and FT 4 7.8-19.4 pg/ml, respectively.
Other measurements included: serum total cholesterol, HDL cholesterol, triglycerides, glucose, insulin, urea, creatinine, and homocysteine. LDL-cholesterol values were calculated by the Friedewald's formula, based upon total cholesterol, HDL-cholesterol and triglycerides levels [LDL = total cholesterol − (HDL cholesterol + triglycerides/5)]. Fasting glucose and insulin values were used to determine the homeostasis model assessment (HOMA) of insulin resistance as [fasting plasma glucose (millimol/l) × fasting plasma insulin (microunits/ml)]/22.5. Creatinine clearance (ml/min) was calculated according to the Cockcroft-Gault equation [29] .
Statistical analysis
Statistical analysis was performed by one of the authors, Giovanni Veronesi. Demographic features, personal habits, and BP parameters (office and 24-h ABPM) at the study inclusion visit (i.e., at diagnosis for the HYPO patients) were summarized as mean (standard deviation) or prevalence for continuous and discrete variables, respectively, in the control group and according to the presence of HYPO, either subclinical or overt. We then tested whether these characteristics were equally distributed among the study groups (control, s-HYPO, o-HYPO) using either an ANOVA F test or a Chi-square test, for continuous and discrete variables, respectively. Since the prevalence of women was slightly lower in the control group as compared to HYPO patients, the analysis of BP parameters was adjusted for sex.
At the inclusion visit, all subjects in the control group and all patients in the HYPO groups were classified as normotensive or hypertensive (further distinguishing MH, WC, and TH) according to the cutoff values reported in Table 1 . The odds ratios (ORs) (with 95 % confidence intervals) of hypertension by type versus normotension in the HYPO groups versus control (reference) were estimated using separated logistic models. Finally, in n = 41 HYPO patients (64 % of the recruited patients), personal habits and BP parameters were reassessed after restoration of euthyroidism with L-T 4 therapy. We estimated the sample mean change and its 95 % confidence interval for in office BP and 24-h ABPM parameters from the diagnosis visit, separately for the s-HYPO and the o-HYPO groups. In these HYPO patients, the prevalence of hypertension (any type) at diagnosis and after correcting hypothyroidism was compared using the McNemar's test for repeated measures. The software used for the analyses was SAS release 9.3.1.
Results
Demographic features of the study group are presented in Table 2 . There was a prevalence of women in all groups, although this was slightly (but not significantly) lower in controls. Mean BMI was slightly but not significantly higher in o-HYPO group (27 ± 4.9 kg/m 2 ) than in s-HYPO (26.1 ± 6.3 kg/m 2 ) and euthyroid (24.6 ± 3.9 kg/m 2 ) groups. Other demographic data and personal habits did not differ in the three groups (Table 2) .
According to NIH criteria for obesity [25] , 38.4 % of the o-HYPO had normal weight, 38.4 % were overweight, and 23.1 % were obese; 50 % of the s-HYPO had normal weight, 36.8 % were overweight, and 13.2 % were obese; and 56 % of the euthyroid subjects had normal weight, 38 % were overweight, and 6 % were obese. Office systolic BP values in hypothyroid patients (122.5 ± 18.4 mmHg in o-HYPO and 121.9 ± 15.1 mmHg in s-HYPO) and controls (118.2 ± 13.9 mmHg; p = 0.4) did not differ. Conversely, office diastolic BP values were significantly higher in o-HYPO (83.3 ± 10 mmHg) and in s-HYPO (80.4 ± 8.8 mmHg) than in controls (75.3 ± 8.5 mmHg) (p = 0.001) ( Table 2 ). In addition, the difference between o-HYPO and s-HYPO groups was significant (p < 0.05).
Twenty-four-hour, daytime, and nighttime systolic and diastolic BP mean values and variability did not differ significantly in the study groups ( Table 2 ). The prevalence of non-dippers was similar in the three groups ( Table 2) .
Prevalence of TH in o-HYPO (11.5 %) and s-HYPO (10.5 %) patients, based on both office BP and 24-h AMBP values, was significantly higher than in controls (8 %, p = 0.03), with no significant difference between the two groups of patients (p = 0.6).
Prevalence of MH was also significantly higher in s-HYPO (26.3 %) and o-HYPO (15.4 %) than in controls (10 %, p = 0.05). Although there was a trend toward a higher prevalence of MH in s-HYPO compared to o-HYPO, this difference did not reach statistical significance. WH (2 %) was less represented among controls than among o-HYPO (19.2 %) or s-HYPO (10.5 %) (p = 0.05).
The OR for hypertension versus normotension confirmed a significantly increased risk to have MH in hypothyroid patients compared to controls (OR 3.29, 1.08-10.08; p = 0.02) ( Table 3) ; OR for MH was slightly higher in s-HYPO (OR 4.00, 1.21-13.28) than in o-HYPO (2.29, 0.54-9.73).
A subgroup of 13 o-HYPO and 28 s-HYPO patients was evaluated after restoration of euthyroidism by L-T 4 (Table 4 ). In the s-HYPO group, normalization of thyroid status was associated with an increase in the prevalence of normotension (82.1 vs 57.2 % at baseline, McNemar's test p value 0.02), with a decreased prevalence of MH (from 25 to 10.7 %), TH (from 10.7 to 3.6 %), and WC (from 7.1 to 3.6 %) (Fig. 1) . After restoration of euthyroidism, in the s-HYPO group, BP profile did not significantly differ from controls ( Table 5 ). As shown in Table 6 , a significant reduction in office systolic and diastolic BP values, mean 24-h, daytime systolic and diastolic BP, and nighttime systolic 
Discussion
We investigated the prevalence of MH in newly diagnosed hypothyroid patient for two main reasons. Firstly, there is an increasing evidence, from meta-analyses of prospective studies in the general population, that MH is associated with target organ damage and cardiovascular events similar to TH [20] [21] [22] [23] . In addition, MH may precede TH, and patients with persistent MH or who progress from MH to TH have a higher left ventricular mass index than normotensive controls [30] . Secondly, although figures on the prevalence and outcome of MH in the general population are available, information regarding this condition in thyroid dysfunction is limited [24] . To our knowledge, this is the first study assessing the prevalence of MH in both o-HYPO and s-HYPO patients, compared with euthyroid healthy controls. We chose to select newly diagnosed hypothyroid patients, never treated for hypertension; these selection criteria, especially lack of treatment with L-T 4 and/or antihypertensive drugs, reduced the number of participants eligible for the study, but also made it possible to avoid potential bias. According to the 2013 European Society of Hypertension and the European Society of Cardiology Guidelines [19] , MH is defined by office BP <140/90 mmHg and 24-h ABPM values ≥130 and/or 80 mmHg or home BP ≥135 and/or 85 mmHg. These criteria were confirmed by the recent Consensus of the European Society of Hypertension for ambulatory BP monitoring [31] . Interestingly, current recommendations stressed that the term "MH" should be properly restricted to untreated individuals [19, 31] . In order to study the BP profile of our population, in association with office BP measurement, we preferred 24-h ABPM to HBPM, because 24-h ABPM allows to assess BP during various daily activities at home, at work, and during sleep, improving the identification of MH [32] . Indeed, Kang et al. [33] recently found that in untreated patients (n = 573), the prevalence of MH significantly differed between 24-h ABPM and HBPM (17.8 vs 13.1 %, respectively).
At clinical measurement, diastolic BP values appeared to be significantly higher in o-HYPO and in s-HYPO than in controls. These findings are in keeping with previous studies showing that o-HYPO may alter BP, particularly diastolic values [2, 8] . In a study of 169 women with o-HYPO [8] , the prevalence of hypertension was nearly threefold higher than in euthyroid controls (14.8 vs 5.5 %). Fommei and Iervasi [10] found that euthyroid normotensive patients had an increase in diastolic BP values after thyroidectomyinduced hypothyroidism. In a survey of 688 consecutive hypertensive outpatients [34] , hypothyroidism was found in 25 (3.6 %): In this subset, diastolic BP fell significantly after adequate L-T 4 replacement therapy. Regarding s-HYPO and hypertension, in two small case-control studies, Luboshitzky et al. [11, 12] observed that mean diastolic BP was higher in 57 and 44 women with s-HYPO than in euthyroid controls, respectively, 82 versus 75 mmHg (p < 0.01) [11] and 84.2 ± 12.4 versus 75.8 ± 10.1 mmHg (p = 0.01) [12] .
At 24-h ABPM, both systolic and diastolic BP average daytime and nighttime values were slightly higher in Table 3 Odds ratios (with 95 % confidence intervals) for hypertension by type versus normotension at the inclusion visit, in the s-and o-HYPO groups versus controls (reference) Odds ratios, 95 % confidence intervals and p values from logistic models Table 4 Demographic data and family history of hypertension at diagnosis, and body mass index and personal habits reevaluated after restoration of euthyroidism, in the subgroup of patients s-HYPO than in o-HYPO. This finding, consistent with a previous study [24] , might be related to a decreased sympathetic nervous system activity in o-HYPO. The observation that in our series, 24-h HR was also significantly lower in o-HYPO (72.3 ± 9.8 bpm) than in s-HYPO (77.1 ± 7.6 bpm, p = 0.02) supports this hypothesis. Twenty-four-hour ABPM showed a slight, but significant higher prevalence of TH in o-HYPO (11.5 %) and s-HYPO (10.5 %) than in controls (8 %, p = 0.03). Moreover, we observed a significantly higher prevalence of MH both in s-HYPO (26.3 %) and in o-HYPO (15.4 %) than in EU (10 %, p = 0.05). MH showed a trend to be more frequent in s-HYPO than in o-HYPO, but differences were not significant. As suggested by Stabouli et al. [35] , one possible explanation might be that in s-HYPO, factors leading to an increase in BP, including vasoconstriction and increased total peripheral resistance, are preponderant with respect to factors associated with a decreased BP, such as a reduced cardiac output, lower sympathetic nervous system activity, reduced sodium reabsorption and glomerular [24] . At variance with our study, hypothyroidism was defined as TSH ≥5 mcU/ml, thus including both overt and subclinical HYPO. Because established MH may be considered as a condition of prehypertension, it would appear that a relationship exists between severity of HYPO and development of overt BP disorders. A higher risk of developing MH is present in the elderly, AfricanAmericans, type 2 diabetes patients, juvenile diabetes, and chronic renal diseases [32] . In addition, several factors can increase out-of-office BP values, including male gender, alcohol consumption, smoking, central obesity, sedentary lifestyle, and job stress [31, 36] . In our study, as in previous studies, the higher prevalence of female patients reflects gender differences in the epidemiology of thyroid diseases. Because MH is more frequent in men, and our population was predominantly female, it is possible that the prevalence of MH be even higher in HYPO male patients. We found no significant difference between HYPO patients and controls regarding the other risk factors for hypertension (positive family history for hypertension, alcohol consumption and smoking, central obesity, and sedentary lifestyle). In particular, BMI resulted slightly higher in HYPO patients, but the difference was not statistically significant, and waist circumference measurement showed a similar distribution of visceral adiposity. These findings suggest that our results would be independent of the influence of these confounders. A limitation of the present study is the small sample size, because of which some results showed a trend, but could not reach a statistical power. Nevertheless, in our opinion, it seems reasonable to conclude that, because 24-h ABPM should be performed in subjects with suspected hypertension [31] , both o-HYPO and s-HYPO patients should be included in this subset of population in view of the fact that they may be normotensive in the office and nevertheless have MH. The observed improvement in BP profile observed in the subgroup of patients with both sand o-HYPO submitted to L-T4 replacement appeared to be more frequent in patients with s-HYPO. This might be related to the occurrence of irreversible changes in o-HYPO. Although caution should be used in the interpretation of these results in view of the small sample size, this may suggest that both TH and, even more evident, MH represent situations justifying the institution of L-T 4 treatment also in patients with s-HYPO.
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